<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01098799</url>
  </required_header>
  <id_info>
    <org_study_id>Dahiliye-2-Urotensin</org_study_id>
    <nct_id>NCT01098799</nct_id>
  </id_info>
  <brief_title>Urotensin II in Chronic Kidney Diseases and Kidney Transplants</brief_title>
  <official_title>Urotensin II in Chronic Kidney Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vakif Gureba Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vakif Gureba Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are planning to study the serum level of Urotensin II in chronic kidney
      disease patients, kidney transplants, and healthy controls.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will determine the urotensin II levels in Chronic kidney disease patients,
      kidney transplants, and healthy controls.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">July 2010</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>serum Urotensin II(UII)level</measure>
    <time_frame>at enrollment</time_frame>
    <description>We tried to compare UII level in normal, chronic kidney disease and kidney transplant patients group</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">110</enrollment>
  <condition>Chronic Renal Disease</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Healthy controls</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chronic kidney disease-1</arm_group_label>
    <description>Chronic kidney disease not taking dialysis treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Kidney Transplant</arm_group_label>
    <description>Kidney transplants</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy controls,CRF patients and kidney transplants aged more than 18
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age more than 18

        Exclusion Criteria:

          -  Inability to give a written consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tufan Tukek, MD</last_name>
    <role>Study Director</role>
    <affiliation>Vakif Gureba Training &amp; Research Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vakif Gureba Training &amp; Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 2, 2010</study_first_submitted>
  <study_first_submitted_qc>April 2, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 5, 2010</study_first_posted>
  <last_update_submitted>June 12, 2013</last_update_submitted>
  <last_update_submitted_qc>June 12, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 13, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vakif Gureba Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Mehmet Hursitoglu</investigator_full_name>
    <investigator_title>Chair</investigator_title>
  </responsible_party>
  <keyword>Urotensin II,Chronic renal disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

